Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Bases de dados
País/Região como assunto
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Medicine (Baltimore) ; 103(17): e38000, 2024 Apr 26.
Artigo em Inglês | MEDLINE | ID: mdl-38669370

RESUMO

This study aimed to assess the clinical utility of blood lactate-to-bicarbonate (L/B) ratio, as a prognostic factor for 28-day in-hospital mortality in children with dengue shock syndrome (DSS), admitted to the pediatric intensive care unit (PICU). This single-center retrospective study was conducted at a tertiary children hospital in southern Vietnam from 2013 to mid-2022. Prognostic models for DSS mortality were developed, using a predefined set of covariates in the first 24 hours of PICU admission. Area under the curves (AUCs), multivariable logistic and Least Absolute Shrinkage and Selection Operator (LASSO) regressions, bootstrapping and calibration slope were performed. A total of 492 children with DSS and complete clinical and biomarker data were included in the analysis, and 26 (5.3%) patients died. The predictive values for DSS mortality, regarding lactate showing AUC 0.876 (95% CI, 0.807-0.944), and that of L/B ratio 0.867 (95% CI, 0.80-0.934) (P values of both biomarkers < .001). The optimal cutoff point of the L/B ratio was 0.25, while that of lactate was 4.2 mmol/L. The multivariable model showed significant clinical predictors of DSS fatality including severe bleeding, cumulative amount of fluid infused and vasoactive-inotropic score (>30) in the first 24 hours of PICU admission. Combined with the identified clinical predictors, the L/B ratio yielded higher prognostic values (odds ratio [OR] = 8.66, 95% confidence interval [CI], 1.96-38.3; P < .01) than the lactate-based model (OR = 1.35, 95% CI, 1.15-1.58; P < .001). Both the L/B and lactate models showed similarly good performances. Considering that the L/B ratio has a better prognostic value than the lactate model, it may be considered a potential prognostic biomarker in clinical use for predicting 28-day mortality in PICU-admitted children with DSS.


Assuntos
Bicarbonatos , Biomarcadores , Mortalidade Hospitalar , Unidades de Terapia Intensiva Pediátrica , Ácido Láctico , Dengue Grave , Humanos , Masculino , Feminino , Estudos Retrospectivos , Prognóstico , Ácido Láctico/sangue , Dengue Grave/sangue , Dengue Grave/mortalidade , Dengue Grave/diagnóstico , Criança , Pré-Escolar , Biomarcadores/sangue , Bicarbonatos/sangue , Unidades de Terapia Intensiva Pediátrica/estatística & dados numéricos , Vietnã/epidemiologia , Valor Preditivo dos Testes , Lactente , Área Sob a Curva
2.
Medicine (Baltimore) ; 102(46): e36054, 2023 Nov 17.
Artigo em Inglês | MEDLINE | ID: mdl-37986332

RESUMO

Dengue-associated complications, including dengue shock syndrome, severe respiratory distress, and pediatric acute liver failure (PALF), are associated with high mortality rates in patients with dengue. There is increasing prevalence of overweight and obesity among children worldwide. Obesity may activate inflammatory mediators, leading to increased capillary permeability and plasma leakage in patients with dengue. Several studies have shown a correlation between obesity and DSS, but did not include dengue fatality or PALF. Therefore, we hypothesized possible associations between obesity and critical dengue-associated clinical outcomes among PICU-admitted children with DSS, including dengue-related mortality, mechanical ventilation (MV) requirements, and dengue-associated PALF. The nutritional status of the participants was assessed using World Health Organization growth charts. A total of 858 participants with complete nutritional data were enrolled in this study. Obesity was significantly associated with risk of severe respiratory failure and MV support (odds ratio = 2.3, 95% CI: 1.31-4.06, P < .01); however, it was not associated with dengue-associated mortality or acute liver failure. Obese pediatric patients with DSS should be closely monitored for severe respiratory distress and the need for high-flow oxygenation support, particularly MV, soon after hospitalization.


Assuntos
Síndrome do Desconforto Respiratório , Dengue Grave , Humanos , Criança , Respiração Artificial , Dengue Grave/complicações , Dengue Grave/terapia , Obesidade/complicações , Obesidade/epidemiologia , Estado Nutricional , Dispneia/complicações , Síndrome do Desconforto Respiratório/terapia , Síndrome do Desconforto Respiratório/complicações
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA